Spire Healthcare Group PLC (LON:SPI) has received an average recommendation of “Hold” from the eight analysts that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is GBX 304.29 ($4.20).
A number of brokerages have recently issued reports on SPI. Liberum Capital increased their target price on Spire Healthcare Group from GBX 270 ($3.73) to GBX 275 ($3.80) and gave the company a “hold” rating in a research report on Friday, January 26th. JPMorgan Chase & Co. reiterated a “neutral” rating and set a GBX 339 ($4.68) target price on shares of Spire Healthcare Group in a research report on Thursday, January 4th. Numis Securities reiterated an “add” rating and set a GBX 341 ($4.71) target price on shares of Spire Healthcare Group in a research report on Monday, October 23rd. Barclays began coverage on Spire Healthcare Group in a research report on Friday, February 2nd. They set an “equal weight” rating and a GBX 270 ($3.73) target price on the stock. Finally, Jefferies Group upgraded Spire Healthcare Group to a “buy” rating and increased their target price for the company from GBX 259 ($3.58) to GBX 290 ($4.01) in a research report on Wednesday, January 17th.
In other news, insider Justin Ash acquired 84,500 shares of the firm’s stock in a transaction on Thursday, November 23rd. The shares were bought at an average price of GBX 237 ($3.27) per share, for a total transaction of £200,265 ($276,685.55). Also, insider Peter R. Bamford acquired 5,000 shares of the firm’s stock in a transaction on Monday, November 27th. The stock was purchased at an average price of GBX 240 ($3.32) per share, for a total transaction of £12,000 ($16,579.17).
TRADEMARK VIOLATION NOTICE: This story was originally published by American Banking News and is owned by of American Banking News. If you are viewing this story on another website, it was illegally copied and republished in violation of United States & international trademark & copyright law. The original version of this story can be viewed at https://www.americanbankingnews.com/2018/02/13/spire-healthcare-group-plc-spi-given-average-recommendation-of-hold-by-brokerages.html.
Spire Healthcare Group Company Profile
Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.